Search
forResearch 5 of 23
- Dihydroartemisinin loaded nanostructured lipid carriers (DHA-NLC): evaluation of pharmacokinetics and tissue distribution after intravenous administration to rats.
- Dihydroartemisinin attenuates benign prostatic hyperplasia in rats by inhibiting prostatic epithelial cell proliferation
- Potential Cosmetic Applications of Dihydroartemisinin
- 28‐Day Repeated Dose Toxicity and Toxicokinetics Study on Dihydroartemisinin (DHA) in SD Rats
- Effects of natural products on skin inflammation caused by abnormal hormones secreted by the adrenal gland
Learn
— no results
Try a deeper search in learn →Community
— no results
Try a deeper search in community →